Abstract
A retrospective, transesophageal study of 51 consecutive patients receiving a left ventricular (LV) assist device (AD) over a 2-year period showed that LVAD-associated LV thrombosis (16%) was predicted by acute myocardial infarction, atrial cannulation, and postimplantation bleeding, and was associated with a fourfold increased risk of stroke compared with patients without thrombosis. LV cannulation, when using short-term LVADs, may decrease the incidence of LV thrombosis, and early transition to Heartmate-LVAD support may improve outcome.
MeSH terms
-
Aged
-
Analysis of Variance
-
Coronary Disease / complications
-
Coronary Disease / therapy
-
Echocardiography, Transesophageal
-
Equipment Failure
-
Female
-
Heart Diseases / diagnostic imaging
-
Heart Diseases / etiology*
-
Heart Diseases / mortality
-
Heart Diseases / therapy
-
Heart Ventricles*
-
Heart-Assist Devices / adverse effects*
-
Humans
-
Incidence
-
Logistic Models
-
Male
-
Middle Aged
-
Predictive Value of Tests
-
Retrospective Studies
-
Risk Factors
-
Thrombosis / diagnostic imaging
-
Thrombosis / etiology*
-
Thrombosis / mortality
-
Thrombosis / therapy
-
Treatment Outcome